Research in our group focuses on advancing the clinical and translational understanding of scarring lung diseases, in particular idiopathic pulmonary fibrosis (IPF) and connective tissue associated interstitial lung disease (ILD). Work in our group encompasses risk factor identification and modification, risk predication modeling and survival, diagnostic tests, genetics, biomarkers, and quality of life, for both patients and their caregivers. Through our research, we hope to better understand the biological mechanisms and clinical behavior of ILD, and ultimately translate that knowledge into improving patients’ quality of life.